<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 2 5 9 0 0 0 0 0 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"DengXian Light";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"\@PMingLiU";
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:.25in;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.25in;
	line-height:150%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:0in;
	line-height:150%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:0in;
	line-height:150%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;
	font-style:italic;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Palatino Linotype",serif;
	color:black;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:200%;
	font-size:16.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-link:"Title Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:200%;
	font-size:16.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-link:"Title Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:200%;
	font-size:16.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-link:"Title Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:200%;
	font-size:16.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:#954F72;
	text-decoration:underline;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-link:"No Spacing Char";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Times New Roman",serif;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-link:Footer;
	font-family:"Times New Roman",serif;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Correspondencedetails, li.Correspondencedetails, div.Correspondencedetails
	{mso-style-name:"Correspondence details";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	line-height:150%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-style:italic;}
p.EndNoteBibliographyTitle, li.EndNoteBibliographyTitle, div.EndNoteBibliographyTitle
	{mso-style-name:"EndNote Bibliography Title";
	mso-style-link:"EndNote Bibliography Title Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	text-indent:.5in;
	line-height:150%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.EndNoteBibliographyTitleChar
	{mso-style-name:"EndNote Bibliography Title Char";
	mso-style-link:"EndNote Bibliography Title";
	font-family:"Times New Roman",serif;}
p.EndNoteBibliography, li.EndNoteBibliography, div.EndNoteBibliography
	{mso-style-name:"EndNote Bibliography";
	mso-style-link:"EndNote Bibliography Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:.5in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.EndNoteBibliographyChar
	{mso-style-name:"EndNote Bibliography Char";
	mso-style-link:"EndNote Bibliography";
	font-family:"Times New Roman",serif;}
p.MDPI39equation, li.MDPI39equation, div.MDPI39equation
	{mso-style-name:"MDPI_3\.9_equation";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:35.45pt;
	text-align:center;
	line-height:13.0pt;
	layout-grid-mode:char;
	font-size:10.0pt;
	font-family:"Palatino Linotype",serif;
	color:black;
	layout-grid-mode:line;}
p.MDPI3aequationnumber, li.MDPI3aequationnumber, div.MDPI3aequationnumber
	{mso-style-name:"MDPI_3\.a_equation_number";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:right;
	font-size:10.0pt;
	font-family:"Palatino Linotype",serif;
	color:black;
	layout-grid-mode:line;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	font-family:"Palatino Linotype",serif;
	color:black;}
span.NoSpacingChar
	{mso-style-name:"No Spacing Char";
	mso-style-link:"No Spacing";}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;}
div.WordSection3
	{page:WordSection3;}
@page WordSection4
	{size:8.5in 11.0in;
	margin:.4in .4in .4in .4in;}
div.WordSection4
	{page:WordSection4;}
@page WordSection5
	{size:11.0in 8.5in;
	margin:.4in .4in .4in .4in;}
div.WordSection5
	{page:WordSection5;}
@page WordSection6
	{size:8.5in 11.0in;
	margin:.4in .4in .4in .4in;}
div.WordSection6
	{page:WordSection6;}
@page WordSection7
	{size:8.5in 11.0in;
	margin:.4in .4in .4in .4in;}
div.WordSection7
	{page:WordSection7;}
@page WordSection8
	{size:8.5in 11.0in;
	margin:.4in .4in .4in .4in;}
div.WordSection8
	{page:WordSection8;}
@page WordSection9
	{size:8.5in 11.0in;
	margin:.4in .4in .4in .4in;}
div.WordSection9
	{page:WordSection9;}
@page WordSection10
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection10
	{page:WordSection10;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink="#954F72">

<div class=WordSection1>

<p class=MsoTitleCxSpFirst align=center style='text-align:center;line-height:
normal'><a name="_Hlk133774678">&nbsp;</a></p>

<p class=MsoTitleCxSpMiddle align=center style='text-align:center;line-height:
normal'>&nbsp;</p>

<p class=MsoTitleCxSpLast align=center style='text-align:center;line-height:
115%'>Development of a Generalized Pharmacokinetic Model to Characterize
Clinical Pharmacokinetics of Monomethyl Auristatin E (MMAE)-Based Antibody-Drug
Conjugates (ADCs)</p>

<p class=MsoNormal align=center style='text-align:center;text-indent:0in;
line-height:200%'><a name="_Hlk133774760">&nbsp;</a></p>

<p class=MsoNormal align=center style='text-align:center;text-indent:0in;
line-height:200%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;text-indent:0in;
line-height:200%'>Hsuan-Ping Chang<sup>1</sup>, Yuen Kiu Cheung<sup>1</sup>,
and Dhaval K. Shah<sup>1</sup>*</p>

<p class=MsoNormal align=center style='text-align:center;text-indent:0in;
line-height:200%'><i>Department of Pharmaceutical Sciences, School of Pharmacy
and Pharmaceutical Sciences, The State University of New York at Buffalo,
Buffalo, NY</i></p>

<p class=Correspondencedetails><span style='font-size:11.0pt;line-height:150%'>&nbsp;</span></p>

<p class=Correspondencedetails><span style='font-size:11.0pt;line-height:150%'>&nbsp;</span></p>

<p class=Correspondencedetails style='line-height:115%'><b><span
style='font-size:11.0pt;line-height:115%'>*Corresponding author:</span></b></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>Dhaval K. Shah, PhD</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>Department of Pharmaceutical Sciences</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>455 Pharmacy Building</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>School of Pharmacy and Pharmaceutical Sciences</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>University at Buffalo</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>The State University of New York, Buffalo, New York
14214-8033</span></p>

<p class=Correspondencedetails style='line-height:115%'><span style='font-size:
11.0pt;line-height:115%'>E-mail: </span><a href="mailto:dshah4@buffalo.edu"><span
style='font-size:11.0pt;line-height:115%'>dshah4@buffalo.edu</span></a></p>

<p class=Correspondencedetails><span style='font-size:11.0pt;line-height:150%'>&nbsp;</span></p>

</div>

<b><span style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span></b>

<div class=WordSection2>

<h1 style='margin-left:0in;text-indent:0in'><span style='text-transform:uppercase'>Abstract</span></h1>

<p class=MsoNormal style='text-indent:0in'>In this manuscript we have developed
a generalized pharmacokinetic (PK) model for monomethyl auristatin E
(MMAE)-based antibody-drug conjugates (ADCs) by analyzing clinical PK data from
18 different ADCs across various dosing regimens, targets, and indications. The
dose-normalized PK profiles supported the generalizability of PK for MMAE-based
ADCs, and the model was capable of simultaneously capturing the PK of four ADC
analytes. Additionally, we established linear relationships between dose and PK
exposure metrics using reported parameters from the literature, enabling the
prediction of typical exposure values across different doses for MMAE-based
ADCs. This is the first comprehensive analysis of PK data across different ADCs
with a similar linker-payload platform. The generalized PK model lays the
groundwork for establishing a generalized exposure-response relationship for
MMAE-based ADCs, potentially supporting clinical pharmacology strategies in the
development of novel ADCs with similar linker-payload.</p>

<p class=MsoNormal style='text-indent:0in'>&nbsp;</p>

<h1 style='margin-left:0in;text-indent:0in'>Statements and Declarations</h1>

<p class=MsoNormal style='text-indent:0in'>Conflict of Interest: Hsuan-Ping
Chang, Yuen Kiu Cheung, and Dhaval K. Shah declare that they have no conflict
of interest to report related to the work presented in this manuscript.</p>

</div>

<span style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<h1><span style='text-transform:uppercase'>1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='text-transform:uppercase'>Introduction</span></h1>

<p class=MsoNormal style='text-indent:0in'>Antibody-drug conjugates (ADCs) have
emerged as a promising class of immunotherapy, particularly in the field of
oncology, with continuous expansion of their indications to other therapeutic
areas such as infectious and autoimmune diseases [1].
In the context of oncology, ADCs leverage monoclonal antibodies (mAbs) to
deliver cytotoxic agents (payloads) to antigen-rich cancer cells, inducing their
death. However, the complex nature of ADCs, containing both large and small
molecules, necessitates the measurement of multiple ADC analytes to understand
their pharmacokinetics (PK) [2].
Given the narrow therapeutic index of ADCs, it is essential to comprehend the
exposure-response (E-R) relationship to optimize dosing regimens and improve
therapeutic outcomes [3].
In fact, understanding the PK of ADCs and exploring which exposure metrics and
which ADC analytes act as key drivers to the efficacy and/or safety of ADCs is
the key step to establishing a reliable E-R relationship [4].
This study focuses on MMAE-based ADCs, which are among the most widely studied
and utilized payloads with an abundance of clinical data, with five out of the
15 currently approved ADCs being MMAE-based. Despite their clinical success,
however, comprehensive analyses of all clinical PK data for MMAE-based ADCs
across various doses, frequencies, targets, and indications are lacking, and it
remains unclear if the PK data are generalizable. As such, our study aims to
evaluate the generalizability of the clinical PK data for MMAE-based ADCs and
develop a generalized PK models that can capture the PK of multiple ADC
analytes measured in the clinic.</p>

<p class=MsoNormal style='margin-top:6.0pt'>A previous study has analyzed the
PK of eight MMAE-based ADCs in phase 1 studies, and revealed similarities in PK
across these MMAE-based ADCs developed by Genentech [5].
In our study, we have conducted a comprehensive literature review to collect
up-to-date clinical PK data for additional ADCs containing vc-MMAE
linker-payload, with multiple indications and targets, various ADC analytes, a
wider range of doses and dosing regimens, and different average drug-antibody
ratios of the ADC formulations. By pooling these collected data together, we
confirmed the generalization of PK for MMAE-based ADCs across different ADCs.
Furthermore, we have developed a generalized population PK model using all
collected PK data. By pooling the reported PK parameters, we established a generalized
relationship between dose and exposure parameters, enabling the prediction of
typical exposure values for different ADC analytes for a typical MMAE-based ADC
at a given dose.</p>

<p class=MsoNormal style='margin-top:6.0pt'>Although numerous published
population PK models exist for MMAE-based ADCs, most of them have been
developed for individual ADCs [6-10] . To the best of our knowledge, no studies
have comprehensively collected PK data across various MMAE-based ADCs and
utilized this data to develop a generalized PK model. Furthermore, existing PK
models only describe selected ADC analytes of an MMAE-based ADC [6-10],
with none of them simultaneously capturing the four ADC analytes commonly
measured in clinics, including conjugated/total mAbs and
unconjugated/conjugated MMAE. In this study, after demonstrating the
generalizability of PK for MMAE-based ADCs, we have developed a generalized
population PK model that is capable of simultaneously capturing all four ADC
analytes in the collected PK data for MMAE-based ADCs.</p>

<p class=MsoNormal style='margin-top:6.0pt'>More specifically, in this
manuscript we have systematically collected clinical PK data from 18 different
MMAE-based ADCs from multiple sources. We demonstrated the PK generalizability
of these 18 MMAE-based ADCs through dose-normalization [5,
11-43]. Additionally, we established generalizable linear relationships between
dose and PK exposure metrics by utilizing reported PK parameters, which enables
prediction of typical values of exposure parameters across different doses for
ADCs. We have also developed for the first time a generalized population PK
model that can simultaneously characterize the PK all four analytes of 18
MMAE-based ADCs [5,
11-43]. The PK model is also incorporated into an R shiny web-based application
to facilitate its usability during clinical development of MMAE-based ADCs.</p>

<span style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:8.0pt;text-align:left;
text-indent:0in;line-height:107%'>&nbsp;</p>

<h1><span style='text-transform:uppercase'>2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='text-transform:uppercase'>Method</span></h1>

<h2 style='margin-left:0in;text-indent:0in'>2.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>PK Data Collection</h2>

<p class=MsoNormal style='text-indent:0in'>A comprehensive literature search
was conducted to identify relevant publications from databases such as PubMed,
Google Scholar, Google, conference proceedings, abstracts, posters, regulatory
documents (i.e., submission packages in FDA and EMA), and web-based resources
like ClinicalTrials.gov. Keywords such as MMAE, vc-MMAE, vendotin, MMAE-based
ADC, and other related terms were used. Studies were selected based on
predetermined criteria, including clinical studies involving ADCs that use
vc-MMAE as a linker payload and the availability of PK profiles for at least
one of the four ADC analytes (total mAb, conjugated mAb, unconjugated MMAE,
conjugated MMAE), without restrictions on indication, study population,
antibody target, or dosing regimens. Control groups in drug-drug interaction
and organ impairment studies were also included. Studies with ADCs conjugated
using different methods (e.g., site-specific conjugation) or different linker
chemistry were excluded. Upon identifying eligible references, for each study,
data for all ADC analytes and all doses were collected. Concentration vs. time profiles
were digitized using WebPlotDigitizer<span style='line-height:150%;color:black'>
</span><span
style='line-height:150%;color:black'>[44]</span>, and the corresponding doses
and units for each profile were recorded to facilitate subsequent data
analysis.</p>

<h2 style='margin-left:0in;text-indent:0in'>2.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>PK Data Analysis</h2>

<p class=MsoNormal style='text-indent:0in'>Each digitized concentration value
represents the mean concentration from each study group in each study. The collected
concentrations were then dose-normalized to 2.4 mg/kg. Dose-normalized PK
profiles of individual ADC analytes from different ADCs were pooled together
and plotted to visually evaluate the generalization across different ADCs and
dosing groups.</p>

<h2 style='margin-left:0in;text-indent:0in'>2.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Development of Dose-Exposure Relationship </h2>

<p class=MsoNormal style='text-indent:0in'>Literature-reported PK parameters of
different ADC analytes (i.e., <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span>, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image002.png"></span>, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=42 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image003.png"></span>,
half-life, CL, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=18 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image004.png"></span>, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image005.png"></span>,
etc.) were collected from various ADCs across different doses. If PK parameters
for a specific ADC were not reported in the literature, digitized PK profiles
were used to calculate the PK parameters for that particular ADC using
Noncompartmental Analysis (NCA) conducted using WinNonlin. PK parameters of ADC
analytes from different ADCs, but at the same dose levels commonly used in
clinics, were then pooled together, and the mean and standard deviation (SD)
were calculated. Regression analysis was performed to examine the relationships
between PK parameters and dose, which provided equations describing the
exposure vs. dose relationship for each ADC analyte. This analysis allows for
the estimation of generalized values of PK parameters with variability for the
four ADC analytes of MMAE-based ADCs at dose levels commonly used in the clinic.</p>

<h2 style='margin-left:0in;text-indent:0in'>2.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>PK Model Development</h2>

<p class=MsoNormal style='text-indent:0in'>The structure of the generalized PK
model is shown in Fig. 1, and the PK model equations are provided in Eqs. 1<a
name="_Hlk133728531">–</a>8. The model describes different ADC analytes,
including ADC (conjugated mAb), conjugated MMAE, unconjugated MMAE, and naked
mAb. The conjugates compartment in Fig. 1 refers to ADC and conjugated MMAE
both. Each ADC analyte is described using a two-compartmental PK model
(parameterized in terms of CL, CLD, V1, and V2).</p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=698
 style='width:523.35pt;border-collapse:collapse'>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=507 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image006.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(1)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=390 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image007.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(2)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=510 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image008.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(3)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=394 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image009.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(4)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=544 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image010.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(5)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=386 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image011.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(6)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=583 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image012.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(7)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=329 height=41
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image013.png"></span></p>
  </td>
  <td width=46 style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>(8)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span style='line-height:
  150%'>&nbsp;</span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='line-height:150%'>&nbsp;</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal>When each conjugate molecule undergoes catabolism
(characterized by <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=41 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image014.png"></span>),
it is assumed to release a certain number of payloads equivalent to the average
drug-antibody ratio (DAR) value at the given time (<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=41 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image014.png"></span>×
DAR). Additionally, the conjugated MMAE can deconjugate from the ADC (<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image015.png"></span>)
and contribute payload molecules to the free MMAE compartment. The formation of
naked mAb, once conjugated mAb releases all its conjugated payloads, is
characterized using <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=26 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image016.png"></span>.
DAR value changes over time are calculated using the real-time concentration of
conjugated MMAE and total mAb (Eq. 9). The model can simultaneously
characterize the plasma PK of 4 ADC analytes commonly measured in the clinic, which
are calculated using Eqs. 10–13.</p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=698
 style='width:523.35pt;border-collapse:collapse'>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=144 height=44
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image017.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(9)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=107 height=44
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image018.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(10)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=176 height=44
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image019.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(11)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=162 height=44
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image020.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(12)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=165 height=44
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image021.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(13)</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>The population PK model estimation includes three parts.
First, all collected PK data of 4 ADC analytes from all ADCs and all dosing
regimens were simultaneously fitted with the generalized PK model. Population
PK parameters, representing inter-ADC and inter-cohort variability, were
estimated using the Stochastic Approximation Expectation Maximization (SAEM)
algorithm in Monolix (2021R2) and were assumed to be lognormally distributed.
Second, the random effect of the model describes variability between different
study groups across various ADCs and discrete dosing groups. The distribution
of random effect variability was assumed to be log-normal and was described by
an exponential error model (Eq. 14). Third, the residual error models,
including additive, proportional, and combined error models, were tested for
total mAb, ADC, conjugated MMAE, and unconjugated MMAE.</p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=698
 style='width:523.35pt;border-collapse:collapse'>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=119 height=27
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image022.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(14)</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='text-indent:.25in'>Model qualification was guided by
the precision of parameter estimates, goodness-of-fit plots (observed versus
model-predicted concentrations), and visual predictive check (VPC) plots. For
VPC plots, one thousand datasets were simulated from the final estimated
parameters, and the median and 5th and 95th percentiles of simulated data were
compared with the observed data.</p>

<h2 style='margin-left:0in;text-indent:0in'>2.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Web-based Application of the PK Model</h2>

<p class=MsoNormal>The PK model dashboard was developed using R (version 4.1.3)
with shiny (version 1.7.4), shinydashboard (version 0.7.2), and shinyjs
(version 2.0.0) packages for design and layout. The ggplot2 (version 3.4.1)
package was used for graphing, dplyr (version 1.0.9) for data manipulation, and
mrgsolve (version 0.11.1) for PK model simulation using estimated typical
values of PK parameters.</p>

<h1><a name="_Hlk133672569"><span style='text-transform:uppercase'>3<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
style='text-transform:uppercase'>Results</span></a></h1>

<h2 style='margin-left:0in;text-indent:0in'>3.1<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Data Collection</h2>

<p class=MsoNormal style='text-indent:0in'>Table 1 provides a summary of the
collected PK data for MMAE-based ADCs from literature and various resources. A
total of 18 MMAE-based ADCs reported in phase I and phase II studies were
identified, resulting in a total of 109 mean PK profiles collected [5, 11-43]. Table 1 details each ADC's name, ADC analytes with PK data reported, dosing
regimen, target, indication, average DAR value, and associated references. Five
of these ADCs, including brentuximab vedotin, polatuzumab vedotin, tisotumab
vedotin, enfortumab vedotin, and disitamab vedotin have been approved by the
FDA. In the clinic, four ADC analytes (total mAb, ADC, conjugated MMAE,
unconjugated MMAE) are commonly measured, with unconjugated MMAE being measured
in most of the studies. The dose levels for these ADCs range from 0.1 to 3.3
mg/kg. Most ADCs are administered every three weeks, while enfortumab vedotin
and disitamab vedotin are also given weekly. Each ADC has different targets,
with four developed for hematological tumors and 14 for solid tumors. The
average DAR for these ADC formulations is 3.5, ranging from 2.7 to 4.</p>

<h2 style='margin-left:0in;text-indent:0in'>3.2<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>PK Profile Generalizability</h2>

<p class=MsoNormal style='text-indent:0in'>To evaluate the generalizability of
MMAE-based ADC PK, we pooled all digitized data and visually assessed the
dose-normalized PK profiles across different ADCs and dosing groups.
Dose-normalized PK profiles of ADC, total mAb, unconjugated MMAE, and
conjugated MMAE were presented (Fig. 2), with each data point representing the
mean concentration of each dosing group in a clinical study. For ADCs with
multiple dosing data, we only presented PK data from the first dose (Fig. 2).
The PK profiles of the four ADC analytes from different MMAE-based ADCs were
found to be comparable, regardless of their targets, tumor indications, and
average DAR.</p>

<p class=MsoNormal>NCA was also conducted using the digitized dose-normalized
PK profiles, and the calculated PK parameters for individual MMAE-based ADCs,
along with the summary statistics (mean ± SD, median, and range), are shown in Table
S1. Despite variability, the exposure (i.e., <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span>, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image002.png"></span>, <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=42 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image003.png"></span>),
distribution (i.e., <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=18 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image004.png"></span>),
and elimination (CL) properties showed no significant differences among
MMAE-based ADCs, as the difference between the maximum and minimum values and
the median was within a two-fold range of the median value. Moreover, for
unconjugated MMAE, PK profiles and calculated PK parameters demonstrate less
variability (CV% &lt; 30%), emphasizing that the PK of released MMAE behaves
like free-form MMAE.</p>

<p class=MsoNormal>Fig. 3 demonstrates the dose-normalized PK profiles of
individual ADCs, with their different analytes plotted together. Within each
ADC, the dose-normalized PK profiles of different ADC analytes across different
doses are comparable, indicating that the possible contribution of lower doses
to non-linear PK for individual MMAE-based ADCs could be negligible. The
generalizable properties of PK profiles support the strategy of developing a
generalized PK model for MMAE-based ADCs in the clinic.</p>

<h2 style='margin-left:0in;text-indent:0in'>3.3<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Relationship Between ADC Dose and PK Parameters</h2>

<p class=MsoNormal style='text-indent:0in'>To provide a handy source for the
clinical PK of MMAE-based ADCs, literature-reported PK parameters of individual
MMAE-based ADCs at commonly used clinical doses for total mAb (Table 2), ADC
(Table 3), unconjugated MMAE (Table 4), and conjugated MMAE (Table 5) are
provided. It was observed that conjugated mAb exhibits a shorter half-life and
higher CL compared to total mAb for ADCs, which may be attributed to
conjugate-induced CL of ADCs. Unconjugated MMAE demonstrates a similar
half-life to conjugated MMAE, but is significantly longer than that of free
small molecule MMAE, suggesting formation rate-limited clearance. </p>

<p class=MsoNormal style='margin-top:6.0pt'>More detailed literature-reported
clinical PK parameters for individual ADCs across a wide dose range (0.1-4
mg/kg) are provided in Table S2 for ADC, Table S3 for total mAb, Table S4 for
conjugated MMAE, and Table S5 for unconjugated MMAE. We also calculated PK
parameters using digitized PK profiles (non-dose-normalized) for individual
MMAE-based ADCs across different doses for total mAb (Table S6), ADC (Table S7),
unconjugated MMAE (Table S8), and conjugated MMAE (Table S9). The calculated
and reported PK parameters were generally comparable, validating the
reliability of the digitized PK data (Table S10). However, we observed one ADC
with reported <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span> and
<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image002.png"></span> values
significantly higher than the range of values across other ADCs, possibly due
to unit reporting errors. This highlights the importance of unit transformation
for different ADC analytes, and in our study, we converted all concentration
units to nM for convenience in PK modeling.</p>

<p class=MsoNormal>Linear regression was performed to establish a quantitative
relationship between ADC dose and exposure matrices (<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span> and
AUC) for conjugated MMAE (Fig 4a), unconjugated MMAE (Fig 4b), ADC (Fig 4c),
and total mAb (Fig 4d). Eqs. 15–18 relate ADC dose (mg/kg) to <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span> for
conjugated MMAE, unconjugated MMAE, ADC, and total mAb, while Eqs. 19–22 relate
ADC dose (mg/kg) to AUC for the four analytes. These equations enable prediction
of the exposure for different ADC analytes for MMAE-based ADCs across doses
ranging from 0.1 to 4 mg/kg.</p>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=698
 style='width:523.35pt;border-collapse:collapse'>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=321 height=30
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image023.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(15)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=337 height=30
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image024.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(16)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=253 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image025.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(17)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=278 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image026.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(18)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=379 height=27
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image027.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(19)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=369 height=27
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image028.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(20)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=300 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image029.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(21)</span></p>
  </td>
 </tr>
 <tr>
  <td width=652 valign=top style='width:489.05pt;padding:0in 0in 0in 0in'>
  <p class=MDPI39equation style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=329 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image030.png"></span></p>
  </td>
  <td width=46 valign=top style='width:34.3pt;padding:0in 0in 0in 0in'>
  <p class=MDPI3aequationnumber style='line-height:150%'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'>(22)</span></p>
  </td>
 </tr>
</table>

</div>

<h2 style='margin-left:0in;text-indent:0in'>3.4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Generalized PK Model Development</h2>

<p class=MsoNormal style='text-indent:0in'>PK parameter estimates and the
associated variability are summarized in Table 6. Including variability on CL,
CLD, V1, and V2 of mAb, CL and V2 of payload, as well as deconjugation
processes improved model fitting, while adding variability on CLD and V1 of
payload did not enhance model performance. A proportional error model best
described the residual variability for all four ADC analytes. Fig. 5 presents
simulated plasma PK profiles of the four ADC analytes at a dose of 2.4 mg/kg
every three weeks for four doses, shown as log (left) and linear (right) scales,
superimposed with observed data dose-normalized to 2.4 mg/kg. The simulations
account for PK parameter variability. Fig. 6 displays the observed versus
population (upper) and individual (lower) predicted-concentration plots, and Fig.
7 shows the VPC plots for the four ADC analytes. The model was able to
simultaneously characterize the PK of four clinically-measured ADC analytes for
MMAE-based ADCs across different targets, indications, and dosing regimens.</p>

<h2 style='margin-left:0in;text-indent:0in'>3.5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Web-based Application of the PK Model</h2>

<p class=MsoNormal style='text-indent:0in'>The developed PK model was
incorporated into a web-based application to enhance its usability. The
application can be accessed using the following link: </p>

<p class=MsoNormal style='text-indent:0in'><a
href="https://biesuniversityatbuffalo.shinyapps.io/MMAE_ADC_PK_MODELS/">https://biesuniversityatbuffalo.shinyapps.io/MMAE_ADC_PK_MODELS/</a>.</p>

<p class=MsoNormal style='text-indent:0in'>Users can select different ADC doses
(mg/kg), frequencies, and average initial DAR. The model-simulated PK profiles
of the four ADC analytes can be plotted together or separately. Maximum and
trough concentrations of each analyte at steady state are also provided in nM
or ug/mL (ng/mL for unconjugated MMAE) units.</p>

<span style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:8.0pt;text-align:left;
text-indent:0in;line-height:107%'>&nbsp;</p>

<h1><a name="_Hlk133672678">4<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>DISCUSSION</a></h1>

<p class=MsoNormal>MMAE is a commonly used payload in ADCs, composing one-third
of FDA-approved ADCs [45]. This has resulted in abundant clinical PK data for
these ADCs, which share the same payload and conjugation method, but different
targets and indications. However, comprehensive analyses for MMAE-based ADCs
across varying dosing regimens, targets, and indications have been limited. To
address this, we aimed to develop a generalized PK model for MMAE-based ADCs,
comprehensively characterizing and evaluating the PK across four
clinically-measured ADC analytes. We first collected and compiled clinical PK
data from 18 different MMAE-based ADCs and confirmed the generalizability of
the collected data through dose-normalization. Additionally, we established
continuous relationships between dose and exposure matrices of ADC analytes by
pooling literature-reported PK parameters across dose ranges, which enables
prediction of typical exposure values across different doses for typical MMAE-based
ADC. Using all collected PK data, we developed a generalized PK model capable
of simultaneously capturing the PK of four ADC analytes and applied the model
to an R shiny app for user-friendly PK predictions.</p>

<p class=MsoNormal style='margin-top:6.0pt'><a name="_Hlk133344643">Numerous
investigations have been conducted on the PK of MMAE-based ADCs, yet most of
them have focused on specific ADCs </a>[19,
21-23, 25, 27-37, 39-41, 43] or those developed by the same company [5].
To our knowledge, this is the first publication to comprehensively collect and
analyze PK data for ADCs with a similar linker-payload platform. These data
cover various dosing regimens, targets, indications, tumor types, drug
loadings, and incorporate all ADC analytes that are commonly measured in
clinics, which enables generalizability of our analyses for MMAE-based ADCs.
However, the data collection cut-off date was toward the end of 2021, and thus
there is potential that some data may not have been included.</p>

<p class=MsoNormal>To establish a universal PK model for characterizing the PK
of MMAE-based ADCs, the initial step involved evaluating and confirming PK
generalizability across these molecules. This was achieved by comparing
dose-normalized concentration-time profiles for various ADCs and doses. Our
analysis demonstrated comparable dose-normalized PK profiles for four ADC
analytes. Notably, unconjugated MMAE displayed similar PK profiles among
different MMAE-based ADCs, with a <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image005.png"></span> of
2 days (range 1–3 days) and an extended half-life (~4 days) compared to naked
MMAE [46],
suggesting consistent payload release properties and formation rate-limited
characteristics among these vc-linker-based ADCs. For individual ADCs,
dose-normalized PK profiles across dose ranges were also comparable (Fig. 3).
Consequently, within the collected dose range, linear PK was assumed, and the
potential contribution of non-linear PK at lower doses was negligible. The
dose-normalized PK profiles of the four ADC analytes support the
generalizability of PK for MMAE-based ADCs and the development of a generalized
PK model.</p>

<p class=MsoNormal>We have proposed a novel PK model capable of simultaneously
capturing all ADC analytes of MMAE-based ADCs, with PK parameters accounting
for inter-ADC and inter-cohort variability (Table 6). <span style='line-height:
150%'>Each ADC analyte is described by central and peripheral compartments.
Deconjugation is assumed to occur in both systemic and tissue compartments.
Upon degradation, ADC can release its payload equivalent to the average DAR
value at a given time. </span>The PK parameters were estimated with good
precision (%RSE &#8804; 10%). Additionally, the estimated PK parameters for the
compartmental PK model (Table 6) correspond to the literature-reported PK
parameters calculated by NCA (Tables 2–5). For instance, the estimated
elimination (including <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=41 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image014.png"></span> and
<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=26 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image016.png"></span> pathway)
and distribution (i.e., <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=90 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image031.png"></span>) of
ADC (conjugated mAb) analytes for MMAE-based ADCs were within the range of
reported CL and <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=18 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image004.png"></span> values
(Table 3). For conjugated MMAE, the estimated total CL (~19.4 mL/day/kg), which
includes degradation (<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=41 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image014.png"></span>)
and deconjugation (<span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image015.png"></span>)
processes, corresponds to the literature-reported CL of conjugated MMAE for MMAE-based
ADCs (Table 5)</p>

<p class=MsoNormal>Important PK characteristics of payload release can be
inferred from the estimated PK parameters associated with unconjugated MMAE.
For instance, a similar terminal slope and half-life were observed between
unconjugated and conjugated MMAE from the PK profiles, while the estimated CL
of unconjugated MMAE was faster than that of conjugated MMAE (861 vs. 12.5
mL/day/kg), demonstrating formation rate-limited kinetics of the released
payload [47]. Additionally, the estimated low <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image032.png"></span> and
high <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image033.png"></span> values,
along with the high <span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=35 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image034.png"></span><span
style='font-size:10.0pt;line-height:150%;color:black'> </span>value, indicate
extensive and rapid tissue distribution of the released MMAE, consistent with
our previous publication investigating the tissue distribution of MMAE [46].</p>

<p class=MsoNormal>Each data point in our analysis represents the mean
concentration of individual treatment groups. Consequently, the random effects
incorporated within the model do not indicate inter-individual variability, but
rather describe the variability among treatment groups from different studies
across different ADCs. Given this context, covariates cannot be included to
reduce the relatively high variability observed in PK parameters. However,
covariates commonly reported as significant for biotherapeutics PK have minimal
impact on ADC PK parameters compared to data variability, and indeed, BW-based
dosing without adjusting for intrinsic and extrinsic factors is sufficient for
ADC dosing strategy [6].
This highlights the feasibility of the current generalized PK model, which
utilizes BW-based parameterization.</p>

<p class=MsoNormal><span style='line-height:150%'>The generalized PK model
exhibits several key features. First, it is capable of simultaneously
describing four commonly measured ADC analytes in clinical settings, while most
published PK models for ADCs predict only specific analytes. Second, as ADCs in
the body act in heterogeneous forms, we use the average DAR value to represent
the overall behavior of ADC molecules. This DAR value changes over time and is
determined by the real-time concentrations of conjugated MMAE and total mAb. Third,
although the model is a compartmental model rather than a physiologically-based
PK model, it mechanistically describes payload release pathways, including
deconjugation and degradation. </span>Lastly, the input for conjugated MMAE
accounts for individual DAR values, reflecting ADC formulation differences
(i.e., conjugated MMAE dose is calculated as ADC dose times initial DAR in the
formulation).</p>

<p class=MsoNormal>Several compartmental population PK models have been
developed for MMAE-based ADCs [6].
These models typically characterize two ADC analytes, including ADC or
conjugated MMAE and unconjugated MMAE. The PK model for polatuzumab vedotin
employs three time-dependent elimination pathways to characterize the transformation
of conjugated MMAE to unconjugated payload [8];
however, it cannot distinguish between deconjugation and degradation processes
of payload release. On the other hand, the PK model for brentuximab vedotin
incorporates deconjugation and degradation processes [7],
while the dynamic of DAR is characterized using an empirical exponential
equation instead of calculating it from real-time data predicted in the model.
For enfortumab vedotin, PK models for ADC and unconjugated payload are
developed separately, limiting their utility in characterizing the overall PK
of ADC molecules [9].
In the case of tisotumab vedotin, a delayed compartment is incorporated to
characterize the unconjugated MMAE [10];
however, this approach may not mechanistically reflect the formation
rate-limited feature of the released payload. Therefore, our PK model offers
several innovative aspects, such as various ADC analyte characterization,
improved DAR handling, and payload release mechanisms, which may provide
advantages over existing models for MMAE-based ADCs.</p>

<p class=MsoNormal>E-R analysis is essential in clinical dose optimization of
ADCs due to their narrow therapeutic window [48].
Given the presence of multiple ADC analytes in the body, selecting the
appropriate ADC analytes and exposure matrices is of significant importance
during the initial decision of ER analysis. Our generalized PK model enables
simultaneous quantitative understanding of different exposure matrices for all
four ADC analytes of MMAE-based ADCs, allowing for a comprehensive examination
of the key drivers of efficacy and safety endpoints. Indeed, our next step is
to link the proposed PK model with pharmacodynamic (PD) endpoints from various
MMAE-based ADCs to develop a generalized E-R relationship for MMAE-based ADCs.</p>

<span style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:8.0pt;text-align:left;
text-indent:0in;line-height:107%'>&nbsp;</p>

<h1>5<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>CONCLUSION</h1>

<p class=MsoNormal>In conclusion, we comprehensively collected and analyzed
clinical PK data from 18 MMAE-based ADCs with varying targets, indications, and
dosing regimens, demonstrating their PK generalizability. We have also developed
a generalized population PK model capable of simultaneously characterizing all
four analytes of MMAE-based ADCs for the first time. We present a linear
relationships between dose and exposure metrics for MMAE-based ADCs by pooling
literature-reported PK values, which enables prediction of typical exposure
values for a given dose. This comprehensive PK analysis, along with the
incorporation of the PK model into a user-friendly web-based application,
facilitates better clinical development and optimization of MMAE-based ADCs.</p>

</div>

<span style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection4>

<h1><span style='text-transform:uppercase'>References</span></h1>

<p class=EndNoteBibliography style='text-indent:0in'>1.         McPherson MJ,
Hobson AD. Pushing the Envelope: Advancement of ADCs Outside of Oncology.
Methods Mol Biol. 2020;2078:23-36.</p>

<p class=EndNoteBibliography style='text-indent:0in'>2.         Saad OM, Shen
BQ, Xu K, Khojasteh SC, Girish S, Kaur S. Bioanalytical approaches for
characterizing catabolism of antibody-drug conjugates. Bioanalysis.
2015;7(13):1583-604.</p>

<p class=EndNoteBibliography style='text-indent:0in'>3.         Colombo R, Rich
JR. The therapeutic window of antibody drug conjugates: A dogma in need of
revision. Cancer Cell. 2022 Nov 14;40(11):1255-63.</p>

<p class=EndNoteBibliography style='text-indent:0in'>4.         Chang H-P, Le
HK, Shah DK. Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates
Administered via Subcutaneous and Intratumoral Routes.  Pharmaceutics; 2023.</p>

<p class=EndNoteBibliography style='text-indent:0in'>5.         Li C, Zhang C,
Li Z, Samineni D, Lu D, Wang B, et al. Clinical pharmacology of vc-MMAE
antibody-drug conjugates in cancer patients: learning from eight first-in-human
Phase 1 studies. MAbs. 2020 Jan-Dec;12(1):1699768.</p>

<p class=EndNoteBibliography style='text-indent:0in'>6.         Liu SN, Li C.
Clinical pharmacology strategies in supporting drug development and approval of
antibody–drug conjugates in oncology. Cancer Chemotherapy and Pharmacology.
2021 2021/06/01;87(6):743-65.</p>

<p class=EndNoteBibliography style='text-indent:0in'>7.         Li H, Han TH,
Hunder NN, Jang G, Zhao B. Population Pharmacokinetics of Brentuximab Vedotin
in Patients With CD30-Expressing Hematologic Malignancies. The Journal of
Clinical Pharmacology. 2017 2017/09/01;57(9):1148-58.</p>

<p class=EndNoteBibliography style='text-indent:0in'>8.         Lu D, Lu T,
Gibiansky L, Li X, Li C, Agarwal P, et al. Integrated Two-Analyte Population
Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin
Lymphoma. CPT: Pharmacometrics &amp; Systems Pharmacology. 2020
2020/01/01;9(1):48-59.</p>

<p class=EndNoteBibliography style='text-indent:0in'>9.         CDR. Center for
Drug Evaluation and Research. MULTI-DISCIPLINE REVIEW of enfortumab vedotin,
APPLICATION NUMBER:761137Orig1s000 <a
href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761137Orig1s000MultiDiscliplineR.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761137Orig1s000MultiDiscliplineR.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>10.       Gibiansky L,
Passey C, Voellinger J, Gunawan R, Hanley WD, Gupta M, et al. Population
pharmacokinetic analysis for tisotumab vedotin in patients with locally
advanced and/or metastatic solid tumors. CPT: Pharmacometrics &amp; Systems
Pharmacology. 2022 2022/10/01;11(10):1358-70.</p>

<p class=EndNoteBibliography style='text-indent:0in'>11.       Center for Drug
Evaluation and Research. Clinical Pharmacology and Biopharmaceutics Review for
Adcetris; Silver Spring (MD); 2011 [cited 2022 Sep 1]. <a
href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/125388Orig1s000ClinPharmR.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/125388Orig1s000ClinPharmR.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>12.       Center for Drug
Evaluation and Research. Clinical Pharmacology Review for Polivy; Silver Spring
(MD); 2018 [cited 2022 Sep 1]. <a
href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761121Orig1s000ClinPharmR.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761121Orig1s000ClinPharmR.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>13.       European
Medicines Agency (EMA) Assessment  report:  Polivy. EMA/CHMP/690748/2019.
Procedure No. EMEA/H/C/004870/0000. 2019 [cited 2022 Sep 1]. <a
href="https://www.ema.europa.eu/en/documents/assessment-report/polivy-epar-public-assessment-report_en.pdf">https://www.ema.europa.eu/en/documents/assessment-report/polivy-epar-public-assessment-report_en.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>14.       Center for Drug
Evaluation and Research. Clinical Pharmacology and Biopharmaceutics Review for
Tivdak; Silver Spring (MD); 2021 [cited 2022 Sep 1]. <a
href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/761208Orig1s000MultidisciplineR.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/761208Orig1s000MultidisciplineR.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>15.       Center for Drug
Evaluation and Research. Multi-discipline Review for Padcev; Silver Spring
(MD); 2019 [cited 2022 Sep 1]. <a
href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761137Orig1s000MultiDiscliplineR.pdf">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761137Orig1s000MultiDiscliplineR.pdf</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>16.       Tsai. M, Han.
HS, Montero. AJ, Tkaczuk. KH, Assad. H, Pusztai. L, et al. Weekly ladiratuzumab
vedotin monotherapy for metastatic triple-negative breast cancer. Annals of
Oncology (2021) 32 (suppl_5): S457-S515. 10.1016/annonc/annonc689.</p>

<p class=EndNoteBibliography style='text-indent:0in'>17.       Younes A,
Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, et al. Brentuximab
vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med. 2010 Nov
4;363(19):1812-21.</p>

<p class=EndNoteBibliography style='text-indent:0in'>18.       Han TH, Gopal
AK, Ramchandren R, Goy A, Chen R, Matous JV, et al. CYP3A-mediated drug-drug
interaction potential and excretion of brentuximab vedotin, an antibody-drug
conjugate, in patients with CD30-positive hematologic malignancies. J Clin
Pharmacol. 2013 Aug;53(8):866-77.</p>

<p class=EndNoteBibliography style='text-indent:0in'>19.       Ott PA, Hamid O,
Pavlick AC, Kluger H, Kim KB, Boasberg PD, et al. Phase I/II study of the
antibody-drug conjugate glembatumumab vedotin in patients with advanced
melanoma. J Clin Oncol. 2014 Nov 10;32(32):3659-66.</p>

<p class=EndNoteBibliography style='text-indent:0in'>20.       Palanca-Wessels
MC, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, et al. Safety and
activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in
relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic
leukaemia: a phase 1 study. Lancet Oncol. 2015 Jun;16(6):704-15.</p>

<p class=EndNoteBibliography style='text-indent:0in'>21.       Yardley DA,
Weaver R, Melisko ME, Saleh MN, Arena FP, Forero A, et al. EMERGE: A Randomized
Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced
Glycoprotein NMB–Expressing Breast Cancer. Journal of Clinical Oncology. 2015
2015/05/10;33(14):1609-19.</p>

<p class=EndNoteBibliography style='text-indent:0in'>22.       Coveler AL, Ko
AH, Catenacci DV, Von Hoff D, Becerra C, Whiting NC, et al. A phase 1 clinical
trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in
patients with advanced pancreatic and gastric cancers. Invest New Drugs. 2016
Jun;34(3):319-28.</p>

<p class=EndNoteBibliography style='text-indent:0in'>23.       Liu JF, Moore
KN, Birrer MJ, Berlin S, Matulonis UA, Infante JR, et al. Phase I study of
safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A
in patients with platinum-resistant ovarian cancer or unresectable pancreatic
cancer. Ann Oncol. 2016 Nov;27(11):2124-30.</p>

<p class=EndNoteBibliography style='text-indent:0in'>24.       Zhao B, Chen R,
O'Connor OA, Gopal AK, Ramchandren R, Goy A, et al. Brentuximab vedotin, an
antibody-drug conjugate, in patients with CD30-positive haematologic
malignancies and hepatic or renal impairment. Br J Clin Pharmacol. 2016
Sep;82(3):696-705.</p>

<p class=EndNoteBibliography style='text-indent:0in'>25.       Advani RH,
Lebovic D, Chen A, Brunvand M, Goy A, Chang JE, et al. Phase I Study of the
Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in
Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Clin Cancer Res.
2017 Mar 1;23(5):1167-76.</p>

<p class=EndNoteBibliography style='text-indent:0in'>26.       Sukumaran S,
Zhang C, Leipold DD, Saad OM, Xu K, Gadkar K, et al. Development and
Translational Application of an Integrated, Mechanistic Model of Antibody-Drug
Conjugate Pharmacokinetics. Aaps j. 2017 Jan;19(1):130-40.</p>

<p class=EndNoteBibliography style='text-indent:0in'>27.       Strickler JH,
Weekes CD, Nemunaitis J, Ramanathan RK, Heist RS, Morgensztern D, et al.
First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab
Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced
Solid Tumors. J Clin Oncol. 2018 Nov 20;36(33):3298-306.</p>

<p class=EndNoteBibliography style='text-indent:0in'>28.       Danila DC,
Szmulewitz RZ, Vaishampayan U, Higano CS, Baron AD, Gilbert HN, et al. Phase I
Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane
Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate
Cancer. J Clin Oncol. 2019 Dec 20;37(36):3518-27.</p>

<p class=EndNoteBibliography style='text-indent:0in'>29.       de Bono JS,
Concin N, Hong DS, Thistlethwaite FC, Machiels JP, Arkenau HT, et al. Tisotumab
vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a
first-in-human, multicentre, phase 1-2 trial. Lancet Oncol. 2019
Mar;20(3):383-93.</p>

<p class=EndNoteBibliography style='text-indent:0in'>30.       Kopp LM,
Malempati S, Krailo M, Gao Y, Buxton A, Weigel BJ, et al. Phase II trial of the
glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab
vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the
Children's Oncology Group. Eur J Cancer. 2019 Nov;121:177-83.</p>

<p class=EndNoteBibliography style='text-indent:0in'>31.       McHugh D,
Eisenberger M, Heath EI, Bruce J, Danila DC, Rathkopf DE, et al. A phase I
study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody
carrying auristatin E, in metastatic castration-resistant prostate cancer.
Invest New Drugs. 2019 Oct;37(5):1052-60.</p>

<p class=EndNoteBibliography style='text-indent:0in'>32.       Petrylak DP,
Kantoff P, Vogelzang NJ, Mega A, Fleming MT, Stephenson JJ, Jr., et al. Phase 1
study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific
membrane antigen, in chemotherapy-refractory prostate cancer. Prostate. 2019
May;79(6):604-13.</p>

<p class=EndNoteBibliography style='text-indent:0in'>33.       Cleary JM, Calvo
E, Moreno V, Juric D, Shapiro GI, Vanderwal CA, et al. A phase 1 study
evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an
anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients
with solid tumors likely to overexpress EGFR. Invest New Drugs. 2020
Oct;38(5):1483-94.</p>

<p class=EndNoteBibliography style='text-indent:0in'>34.       Gerber DE,
Infante JR, Gordon MS, Goldberg SB, Martín M, Felip E, et al. Phase Ia Study of
Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients
with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. Clin
Cancer Res. 2020 Jan 15;26(2):364-72.</p>

<p class=EndNoteBibliography style='text-indent:0in'>35.       Moore KN, Birrer
MJ, Marsters J, Wang Y, Choi Y, Royer-Joo S, et al. Phase 1b study of
anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in
patients with platinum-sensitive recurrent ovarian cancer. Gynecol Oncol. 2020
Sep;158(3):631-9.</p>

<p class=EndNoteBibliography style='text-indent:0in'>36.       Rosenberg J,
Sridhar SS, Zhang J, Smith D, Ruether D, Flaig TW, et al. EV-101: A Phase I
Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive
Solid Tumors, Including Metastatic Urothelial Carcinoma. J Clin Oncol. 2020 Apr
1;38(10):1041-9.</p>

<p class=EndNoteBibliography style='text-indent:0in'>37.       Shemesh CS,
Agarwal P, Lu T, Lee C, Dere RC, Li X, et al. Pharmacokinetics of polatuzumab
vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin
lymphoma. Cancer Chemotherapy and Pharmacology. 2020 2020/05/01;85(5):831-42.</p>

<p class=EndNoteBibliography style='text-indent:0in'>38.       Shi R, Lu T, Ku
G, Ding H, Saito T, Gibiansky L, et al. Asian race and origin have no
clinically meaningful effects on polatuzumab vedotin pharmacokinetics in
patients with relapsed/refractory B-cell non-Hodgkin lymphoma. Cancer Chemother
Pharmacol. 2020 Sep;86(3):347-59.</p>

<p class=EndNoteBibliography style='text-indent:0in'>39.       Takahashi S,
Uemura M, Kimura T, Kawasaki Y, Takamoto A, Yamaguchi A, et al. A phase I study
of enfortumab vedotin in Japanese patients with locally advanced or metastatic
urothelial carcinoma. Invest New Drugs. 2020 Aug;38(4):1056-66.</p>

<p class=EndNoteBibliography style='text-indent:0in'>40.       Camidge DR,
Morgensztern D, Heist RS, Barve M, Vokes E, Goldman JW, et al. Phase I Study of
2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate
Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung
Carcinoma. Clin Cancer Res. 2021 Nov 1;27(21):5781-92.</p>

<p class=EndNoteBibliography style='text-indent:0in'>41.       Fujiwara Y,
Kenmotsu H, Yamamoto N, Shimizu T, Yonemori K, Ocampo C, et al. Phase 1 study
of telisotuzumab vedotin in Japanese patients with advanced solid tumors.
Cancer Med. 2021 Apr;10(7):2350-8.</p>

<p class=EndNoteBibliography style='text-indent:0in'>42.       Kinoshita T,
Hatake K, Yamamoto K, Higuchi Y, Murakami S, Terui Y, et al. Safety and
pharmacokinetics of polatuzumab vedotin in Japanese patients with
relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation
study. Jpn J Clin Oncol. 2021 Jan 1;51(1):70-7.</p>

<p class=EndNoteBibliography style='text-indent:0in'>43.       Xu Y, Wang Y,
Gong J, Zhang X, Peng Z, Sheng X, et al. Phase I study of the recombinant
humanized anti-HER2 monoclonal antibody-MMAE conjugate RC48-ADC in patients
with HER2-positive advanced solid tumors. Gastric Cancer. 2021
Jul;24(4):913-25.</p>

<p class=EndNoteBibliography style='text-indent:0in'>44.       Rohatgi, A.
(2022). WebPlotDigitizer (Version 4.6) [Computer software]. Retrieved from <a
href="https://automeris.io/WebPlotDigitizer">https://automeris.io/WebPlotDigitizer</a>.</p>

<p class=EndNoteBibliography style='text-indent:0in'>45.       Fu Z, Li S, Han
S, Shi C, Zhang Y. Antibody drug conjugate: the &quot;biological missile&quot;
for targeted cancer therapy. Signal Transduct Target Ther. 2022 Mar 22;7(1):93.</p>

<p class=EndNoteBibliography style='text-indent:0in'>46.       Chang HP, Cheung
YK, Shah DK. Whole-Body Pharmacokinetics and Physiologically Based
Pharmacokinetic Model for Monomethyl Auristatin E (MMAE). J Clin Med. 2021 Mar
23;10(6).</p>

<p class=EndNoteBibliography style='text-indent:0in'>47.       Chang HP, Li Z,
Shah DK. Development of a Physiologically-Based Pharmacokinetic Model for
Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice.
Pharm Res. 2022 Jan;39(1):1-24.</p>

<p class=EndNoteBibliography style='text-indent:0in'>48.       Ruiz-Garcia A,
Baverel P, Bottino D, Dolton M, Feng Y, González-García I, et al. A
comprehensive regulatory and industry review of modeling and simulation
practices in oncology clinical drug development. Journal of Pharmacokinetics
and Pharmacodynamics. 2023 2023/03/04.</p>

<p class=EndNoteBibliography style='text-indent:0in'>49.       Yardley DA,
Weaver R, Melisko ME, Saleh MN, Arena FP, Forero A, et al. EMERGE: A Randomized
Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced
Glycoprotein NMB-Expressing Breast Cancer. J Clin Oncol. 2015 May
10;33(14):1609-19.<br clear=all style='page-break-before:always'>
</p>

<p class=EndNoteBibliography style='text-indent:0in'>&nbsp;</p>

<h1 align=center style='text-align:center'><a name="_Hlk133747044"><span
style='font-size:20.0pt;line-height:150%'>Tables</span></a></h1>

<p class=MsoNoSpacing style='line-height:115%'><span style='font-family:"Times New Roman",serif'>&nbsp;</span></p>

</div>

<span style='font-size:11.0pt;line-height:115%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection5>

<h1 style='margin-top:0in;line-height:115%'><span class=Heading1Char>Table 1.</span>
<span style='font-weight:normal'>Summary of clinical PK data for MMAE-based ADCs.</span></h1>

<table class=MsoTableGrid border=0 cellspacing=0 cellpadding=0 width="101%"
 style='width:101.12%;border-collapse:collapse;border:none'>
 <tr style='height:11.8pt'>
  <td width="15%" style='width:15.54%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC</span></p>
  </td>
  <td width="18%" style='width:18.42%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Reported PK Analytes<sup>b</sup></span></p>
  </td>
  <td width="20%" style='width:20.82%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Dose (mg/kg)</span></p>
  </td>
  <td width="7%" style='width:7.5%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Frequency</span></p>
  </td>
  <td width="7%" style='width:7.44%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Target</span></p>
  </td>
  <td width="16%" style='width:16.48%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Indications</span></p>
  </td>
  <td width="6%" style='width:6.04%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Average DAR</span></p>
  </td>
  <td width="7%" style='width:7.76%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 2.9pt 0in 2.9pt;height:11.8pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>References</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Brentuximab vedotin<sup>a</sup></span></p>
  </td>
  <td width="18%" style='width:18.42%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.2, 1.8, 2.7</span></p>
  </td>
  <td width="7%" style='width:7.5%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>CD30</span></p>
  </td>
  <td width="16%" style='width:16.48%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Hodgkin lymphoma</span></p>
  </td>
  <td width="6%" style='width:6.04%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4</span></p>
  </td>
  <td width="7%" style='width:7.76%;border:none;padding:0in 2.9pt 0in 2.9pt;
  height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[11, 17, 18, 24]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Polatuzumab vedotin<sup>a</sup></span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.1, 0.25, 0.5, 1, 1.4,
  1.8, 2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>CD79b</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>non-Hodgkin lymphoma</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[12, 13, 20, 37, 38, 42]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Pinatuzumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>CD22</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>non-Hodgkin lymphoma</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[25]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Lifastuzumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Napi2b</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Ovarian, lung</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[34, 35]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Losatuxizumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.3, 0.45, 0.67, 1, 1.5,
  2.25, 3</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>EGFR</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>EGFR-dependent solid
  tumors</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[33]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Tisotumab vedotin<sup>a</sup></span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.3, 0.6, 0.9, 1.2, 1.5,
  1.8, 2, 2.2</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>tissue factor</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Cervical</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[14, 29]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Telisotuzumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.15, 0.3, 0.6, 1.2, 1.8,
  1.9, 2.4, 2.7, 3.0, 3.3</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>c-Met</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Non-small cell lung cancer</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[27, 40, 41]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Glembatumumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.88</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>gpNMB</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Melanoma</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.7</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[19, 21, 30]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ASG-5ME</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.3, 0.6, 1.2, 1.8, 2.4,
  2.7, 3</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>SLC44A4</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Pancreatic, gastric,
  prostate</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[22, 31]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Ladiratuzumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1, 1.25, 1.5, 2.5</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>LIV-1</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Breast (TNBC, HR+/HER2-)</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[16]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>PSMA ADC</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.4, 0.7, 1.1, 1.6, 1.8,
  2, 2.2, 2.5, 2.8</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>PSMA</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Prostate cancer</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[32]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Vandortuzumab vedotin</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.33, 0.45, 0.67, 1, 2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Steap1</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Prostate cancer</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 26, 28]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>DEDN6526A</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ETBR</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Melanoma</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>DMOT4039A</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>MsLN</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Ovarian, pancreatic</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>DMUC5754A</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>MUC16</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Ovarian, pancreatic</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 23]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>DFRF4539A</span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>acMMAE, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.4</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>FcRH5</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Multiple myeloma</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Enfortumab vedotin<sup>a</sup></span></p>
  </td>
  <td width="18%" style='width:18.42%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.5. 0.75, 1, 1.25</span></p>
  </td>
  <td width="7%" style='width:7.5%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>QW</span></p>
  </td>
  <td width="7%" style='width:7.44%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Nectin-4</span></p>
  </td>
  <td width="16%" style='width:16.48%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Urothelial</span></p>
  </td>
  <td width="6%" style='width:6.04%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4</span></p>
  </td>
  <td width="7%" style='width:7.76%;padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[15, 36, 39]</span></p>
  </td>
 </tr>
 <tr style='height:.3in'>
  <td width="15%" style='width:15.54%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Disitamab vedotin<sup>a</sup></span></p>
  </td>
  <td width="18%" style='width:18.42%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>ADC, Tmab, unMMAE</span></p>
  </td>
  <td width="20%" style='width:20.82%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.1, 0.5, 1, 2, 2.5, 3.0</span></p>
  </td>
  <td width="7%" style='width:7.5%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>QW, Q3W</span></p>
  </td>
  <td width="7%" style='width:7.44%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>HER2</span></p>
  </td>
  <td width="16%" style='width:16.48%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>Gastric, urothelial</span></p>
  </td>
  <td width="6%" style='width:6.04%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4</span></p>
  </td>
  <td width="7%" style='width:7.76%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 2.9pt 0in 2.9pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[43]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in;
line-height:normal'><span style='font-size:10.0pt'>ADC conjugated antibody, unMMAE
unconjugated MMAE, acMMAE conjugated MMAE, Tmab total antibody</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in;
line-height:normal'><sup><span style='font-size:10.0pt'>a </span></sup><span
style='font-size:10.0pt'>Received FDA approval</span><span style='font-size:
10.0pt'><br clear=all style='page-break-before:always'>
</span></p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection6>

<h1 style='margin-top:0in;line-height:115%'>Table 2. <span style='font-weight:
normal'>Literature reported PK parameters for total antibody analyte for
MMAE-based ADCs.</span></h1>

<table class=TableGrid1 border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:.3in'>
  <td width="8%" nowrap style='width:8.92%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Dose (mg/kg)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=27 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image035.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=42 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image036.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=39 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image037.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" style='width:13.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=24 height=25
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image038.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(day)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>CL (mL/day/kg)</span></b></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=17 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image039.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(mL/kg)</span></b></p>
  </td>
  <td width="12%" style='width:12.34%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Reference<sup>b</sup></span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Polatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.8</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>268 ± 68.6</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>776<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1590 ± 919</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.70 ± 2.98</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>17.1 ± 16.5</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>87.8 ± 24.4</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[13, 20, 38, 42]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>254 ± 20.9</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1212 ± 444<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1415 ± 176</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>6.90 ± 0.797</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>15.4 ± 3.37</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>97.8 ± 17.5</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 12, 13, 20]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Pinatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>275 ± 18.5</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1687 ± 860<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1592 ± 413</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>9.03 ± 3.41</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>14.5 ± 4.90</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>115 ± 24.1</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 25]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Lifastuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>336 ± 36.2</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1505 ± 337<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1516 ± 307</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>6.84 ± 0.709</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>11.5 ± 2.36</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>89.2 ± 26.8</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 34, 35]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><a name="_Hlk114824714"><b><span style='font-size:10.0pt'>Losatuxizumab
  vedotin</span></b></a></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.5</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>167<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>528<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>563<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.60</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>17.8<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>108<sup>a</sup></span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[33]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Glembatumumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.88</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>347 ± 52.8</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>801 ± 222</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>864 ± 195</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.53 ± 0.0666</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>19.5 ± 2.09</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>34.5 ± 5.71</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[19, 30, 49]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>ASG-5ME</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>385 667 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>22 156<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2224 667<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2404<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.65 ± 0.170</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6.65<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>27.8</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.7</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>334 000 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>10 370<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1802 000<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2005<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>9.87 ± 1.03</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>8.98<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>55.3</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><a name="_Hlk125311837"></a><a name="_Hlk125311884"><b><span
  style='font-size:10.0pt'>PSMA ADC</span></b></a></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>320</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><sup><span style='font-size:10.0pt'>-</span></sup></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>736</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1.84</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>28.1</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>68.9</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[32]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Vandortuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><a name="_Hlk125311892"><b><span style='font-size:10.0pt'>2.4</span></b></a></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>374</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1822 ± 61.4<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2100</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>7.52</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.24</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>63.2</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[26, 28]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DEDN6526A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>303</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>827<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>853</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.92</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>20.9</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>70.6</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DMOT4039A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>249</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>902<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>800</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>4.26</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>23.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>118</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DMUC5754A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>275</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>930<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1167</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6.33</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>15.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>93.1</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DFRF4539A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>373</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1744<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2007</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6.00</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>9.02</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>61.5</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 23]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Enfortumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.25</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>247 ± 42.6</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>532 ± 60.1</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>725 ± 125<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.94 ± 0.257<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>11.8 ± 2.2<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>44.5 ± 4.9<sup>a</sup></span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[15, 36, 39]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Disitamab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>373</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1267</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1267</span></p>
  </td>
  <td width="13%" style='width:13.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.53</span></p>
  </td>
  <td width="13%" nowrap style='width:13.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>33.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.74%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>72.4</span></p>
  </td>
  <td width="12%" style='width:12.34%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[43]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><a
name="_Hlk125894987"></a><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=30 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image040.png"></span><span
style='font-size:10.0pt;line-height:150%'> </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'>, </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=37 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image042.png"></span><span
style='font-size:10.0pt;line-height:150%'> were converted to nanomolar
concentration units, CL and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=17 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image043.png"></span><span
style='font-size:10.0pt;line-height:150%'> were presented as per body weight
units, and in case the unit was not reported as per body weight units, the
reported values were divided by 70 kg, - not available</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>a </span></sup><span
style='font-size:10.0pt;line-height:150%'>Values not available from the
literature and were calculated based on digitalized concentration-time profiles</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>b </span></sup><span
style='font-size:10.0pt;line-height:150%'>Data are shown as mean ± standard
deviation (SD) of reported values from multiple references. When the value was
reported in one literature, only the mean value was provided</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>c </span></sup><span
style='font-size:10.0pt;line-height:150%'>The reported units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> (mg/mL) and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> (day·mg/mL) provide ~1000 higher
values than the average reported values of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> for ADC analytes of MMAE-based ADCs,
and thus the units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> should be corrected to µg/mL and
day*µg/mL, respectively<br clear=all style='page-break-before:always'>
</span></p>

<h1 style='line-height:115%'>Table 3. <span style='font-weight:normal'>Literature
reported PK parameters for ADC (i.e., conjugated antibody) analyte for MMAE-based
ADCs.</span></h1>

<table class=TableGrid2 border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:.3in'>
  <td width="8%" nowrap style='width:8.92%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Dose (mg/kg)</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=29 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image045.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=44 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image046.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:10.0pt'><img width=42 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image047.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" style='width:13.58%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=25 height=25
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image048.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(day)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>CL (mL/day/kg)</span></b></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=18 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image049.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(mL/kg)</span></b></p>
  </td>
  <td width="10%" style='width:10.72%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Reference<sup>b</sup></span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Brentuximab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.2</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>144 ± 15.9</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>286 ± 47.4</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>334 ± 23.3</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.75 ± 1.35</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>26.7 ± 1.84</span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>109 ± 35.4</span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[11, 18, 24]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.8</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>224 ± 18.5</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>511</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>564 ± 49.5</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.91 ± 0.831</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>24.4 ± 1.15</span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>126 ± 15.0</span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[11, 17, 18]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Losatuxizumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.5</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>167 ± 18.9<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>430 ± 154<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>445 ± 170<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.5</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>24.2 ± 9.26<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>98.8 ± 1.68<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[33]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Tisotumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.0</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>215</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>349</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>370<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.86<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>36<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>58.5<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[29]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.2</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>370</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>566</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>717<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.18<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>20.5<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>40.9<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[14]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Telisotuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>403 ± 46.0</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1382</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1314 ± 115</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.18</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>12.9 ± 1.58<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>58.3 ± 9.25<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[27, 41]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.7</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>386 ± 48.8</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1099</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1281 ± 232</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.91</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>14.9 ± 0.985<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>69.0 ± 9.18<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[27, 41]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Glembatumumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.88</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>297 ± 73.1</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>644 ± 21.9</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>497 ± 171</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.23 ± 0.133</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>31.1 ± 8.49</span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>43.9 ± 4.53</span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>[19, 30, 49]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>ASG-5ME</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>440 334 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>129 636<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1593 333<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1427<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6.87</span><span
  style='font-size:10.0pt'>± 0.233</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>11.2<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>40.8</span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.7</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>373 000 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>66 468<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1422 000<sup>c</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1363<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>7.40</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>13.2<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>121<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Ladiratuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>549<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1083<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1611<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.56<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>10.3<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>65.9<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[16]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>PSMA ADC</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>267</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>408<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>364</span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.69</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>55.9</span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>104</span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[32]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Enfortumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.25</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>187 ± 29.6</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>220 ± 19.4</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>285 ± 37.2<sup>a</sup></span></p>
  </td>
  <td width="13%" style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.35</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>29.6 ± 4.18<sup>a</sup></span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>70.1 ± 13.5<sup>a</sup></span></p>
  </td>
  <td width="10%" style='width:10.72%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[15, 36, 39]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Disitamab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="8%" nowrap style='width:8.92%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.08%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>353</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>306</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>306</span></p>
  </td>
  <td width="13%" style='width:13.58%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.90</span></p>
  </td>
  <td width="13%" nowrap style='width:13.58%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>55.2</span></p>
  </td>
  <td width="11%" nowrap style='width:11.96%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>159</span></p>
  </td>
  <td width="10%" style='width:10.72%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[43]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=30 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image040.png"></span><span
style='font-size:10.0pt;line-height:150%'> </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'>, </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=37 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image042.png"></span><span
style='font-size:10.0pt;line-height:150%'> were converted to nanomolar
concentration units, CL and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=17 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image043.png"></span><span
style='font-size:10.0pt;line-height:150%'> were presented as per body weight
units, and in case the unit was not reported as per body weight units, the
reported values were divided by 70 kg, - not available</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>a </span></sup><span
style='font-size:10.0pt;line-height:150%'>Values not available from the
literature and were calculated based on digitalized concentration-time profiles</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>b </span></sup><span
style='font-size:10.0pt;line-height:150%'>Data are shown as mean ± standard
deviation (SD) of reported values from multiple references. When the value was
reported in one literature, only the mean value was provided</span></p>

<p class=MsoNormal align=left style='text-align:left;text-indent:0in'><sup><span
style='font-size:10.0pt;line-height:150%'>c </span></sup><span
style='font-size:10.0pt;line-height:150%'>The reported units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> (mg/mL) and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> (day·mg/mL) provide ~1000 higher
values than the average reported values of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> for ADC analytes of MMAE-based ADCs,
and thus the units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> should be corrected to µg/mL and
day*µg/mL, respectively</span></p>

</div>

<span style='font-size:10.0pt;line-height:150%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection7>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:
0in;text-indent:0in;line-height:115%'>Table 4. <span style='font-weight:normal'>Literature
reported PK parameters of unconjugated MMAE analyte for MMAE-based ADCs.</span></h1>

<div align=center>

<table class=TableGrid3 border=0 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:18.4pt'>
  <td width="10%" nowrap style='width:10.48%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Dose (mg/kg)</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=26 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image050.png"></span><b><sup><span
  style='font-size:10.0pt'>b</span></sup></b></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(day)</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=27 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image035.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(nM)</span></b></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=42 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image036.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="14%" style='width:14.6%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=39 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image037.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=24 height=25
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image038.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(day)</span></b></p>
  </td>
  <td width="16%" style='width:16.4%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Reference<sup>b</sup></span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Brentuximab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.2</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.07 (1.07, 3.00)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.46 ± 1.58</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>47.6 ± 3.44<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>40.7 ± 14.0</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.42 ± 0.410</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[11, 17, 18]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.8</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.09 (1.97, 2.09)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>6.53 ± 0.705</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>50.1</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>44.4 ± 10.3</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.42 ± 0.312</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[11, 18, 24]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Polatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.8</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.60 (2.49, 5.98)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.29 ± 2.62</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>29.8 ± 2.31</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>51.1 ± 37.3</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.30 ± 0.495</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[13, 20, 37, 38, 42]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.58 (2.95, 3.94)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>9.75 ± 1.68</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>74.2 ± 17.7<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>80.1 ± 9.01</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.84 ± 0.401</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 12, 13, 20, 37]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Pinatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.32 (2.87, 4.10)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.70 ± 1.20</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>59.3 ± 23.9<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>70.8 ± 11.4</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.47 ± 0.483</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 25]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Lifastuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.06</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.86 ± 1.59</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>59.4 ± 14.7<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>52.3 ± 14.8</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.94 ± 0.294</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 34, 35]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Losatuxizumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.5</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.00<sup>a</sup></span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.27<sup>a</sup></span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>30.7<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>31.4<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.20</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[33]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Tisotumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.2</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>7.00<sup>a</sup></span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>6.80</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>36.9</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>89.1<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>6.88<sup>a</sup></span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[14]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Telisotuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>7.02</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.35</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>31.0</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>35.2<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.80</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[41]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.7</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>7.02</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.90</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>44.3</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>68.9 ± 1.13<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.01</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[41]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Glembatumumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.88</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.53 (1.06, 5.05)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>7.87 ± 0.420</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>77.9 ± 5.09</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>78.5 ± 26.4</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.02 ± 0.311</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[19, 30, 49]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>ASG-5ME</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.60</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6685 237 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>984 829<sup>c</sup></span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>4.82E+10<sup>c</sup></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>&nbsp;</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>107<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.06</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.7</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.30</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>5919 220 ±</span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1083 312<sup>c</sup></span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>7.20E+10<sup>c</sup></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>&nbsp;</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>88.7<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.39</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[31]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Ladiratuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3.00<sup>a</sup></span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.24<sup>a</sup></span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>46.6<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>159<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>11.9<sup>a</sup></span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[16]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>PSMA ADC</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.49</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>12.8</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>90.5<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>99.2</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.68</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[32]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.99</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>7.95</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>61.0<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>60.3</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.91</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[32]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Vandortuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.00</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>7.88</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>61.0</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>62.5</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.62</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[26, 28]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DEDN6526A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.07</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>9.36</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>77.9<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>70.1</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.99</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DMOT4039A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.03</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>6.17</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>52.2<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>46.9</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.35</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DMUC5754A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2.96</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>9.76</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>77.5<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>80.2</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.76</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DFRF4539A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.10</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>4.39</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>49.3<sup>a</sup></span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>49.2</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>5.00</span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 23]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Enfortumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.25</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.01 (1.94, 2.07)</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.20 ± 1.15</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>37.2 ± 34.8</span></p>
  </td>
  <td width="14%" style='width:14.6%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>44.2 ± 3.28<sup>a</sup></span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.27 ± 1.15<sup>a</sup></span></p>
  </td>
  <td width="16%" style='width:16.4%;padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[15, 36, 39]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=7 style='width:100.0%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Disitamab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.48%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.5</span></b></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.99</span></p>
  </td>
  <td width="15%" nowrap style='width:15.6%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>8.36</span></p>
  </td>
  <td width="14%" nowrap style='width:14.34%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>52.9</span></p>
  </td>
  <td width="14%" style='width:14.6%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>57.5</span></p>
  </td>
  <td width="12%" nowrap style='width:12.98%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2.55</span></p>
  </td>
  <td width="16%" style='width:16.4%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[43]</span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal style='text-indent:0in'><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=30 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image040.png"></span><span
style='font-size:10.0pt;line-height:150%'> </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'>, </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=37 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image042.png"></span><span
style='font-size:10.0pt;line-height:150%'> were converted to nanomolar
concentration units, CL and </span><span style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=17 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image043.png"></span><span
style='font-size:10.0pt;line-height:150%'> were presented as per body weight
units, and in case the unit was not reported as per body weight units, the
reported values were divided by 70 kg</span></p>

<p class=MsoNormal style='text-indent:0in'><sup><span style='font-size:10.0pt;
line-height:150%'>a </span></sup><span style='font-size:10.0pt;line-height:
150%'>Values not available from the literature and were calculated based on
digitalized concentration-time profiles</span></p>

<p class=MsoNormal style='text-indent:0in'><sup><span style='font-size:10.0pt;
line-height:150%'>b </span></sup><span style='font-size:10.0pt;line-height:
150%'>Data are shown as mean ± standard deviation (SD) or mean (range) of
reported values from multiple references. When the value was reported in one
literature, only the mean value was provided</span></p>

<p class=MsoNormal style='text-indent:0in'><sup><span style='font-size:10.0pt;
line-height:150%'>c </span></sup><span style='font-size:10.0pt;line-height:
150%'>The reported units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> (mg/mL) and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> (day·mg/mL) provide ~1000,000 higher
values than the average reported values of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> for free MMAE of MMAE-based ADCs,
and thus the units of </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=27 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image044.png"></span><span
style='font-size:10.0pt;line-height:150%'> and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'> should be corrected to ng/mL and day&#8729;ng/mL,
respectively</span></p>

</div>

<span style='font-size:10.0pt;line-height:150%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection8>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:
0in;text-indent:0in;line-height:115%'>Table 5. <span style='font-weight:normal'>Literature
reported PK parameters for conjugated MMAE analyte for MMAE-based ADCs.</span></h1>

<table class=TableGrid4 border=1 cellspacing=0 cellpadding=0 width="100%"
 style='width:100.0%;border-collapse:collapse;border:none'>
 <tr style='height:.3in'>
  <td width="10%" nowrap style='width:10.56%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Dose (mg/kg)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=29 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image045.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=44 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image046.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:10.0pt'><img width=42 height=26
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image047.png"></span><b><span
  style='font-size:10.0pt'> (day·nM)</span></b></p>
  </td>
  <td width="13%" style='width:13.12%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=25 height=25
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image048.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(day)</span></b></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>CL (mL/day/kg)</span></b></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif'><img
  width=18 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image049.png"></span></p>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>(mL/kg)</span></b></p>
  </td>
  <td width="13%" style='width:13.14%;border-top:solid windowtext 1.5pt;
  border-left:none;border-bottom:solid windowtext 1.5pt;border-right:none;
  padding:0in 5.4pt 0in 5.4pt;height:.3in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Reference<sup>b</sup></span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Polatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>1.8</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>872 ± 185</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3539 ± 812<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2860 ± 429</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.52 ± 1.23</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>18.8 ± 6.72</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>81.6 ± 15.5</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[13, 20, 37, 38, 42]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1241 ± 29.3</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3860 ± 1435<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3961 ± 431</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.39 ± 0.801</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>18.0 ± 2.82</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>74.4 ± 18.4</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 12, 13, 20]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Pinatuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1205 ± 42.2</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4215 ± 2216<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3187 ± 634</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.53 ± 1.88</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>23.2 ± 3.70</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>94.4 ± 15.5</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt'>[5, 25]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Lifastuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1236 ± 143</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4231 ± 1599<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3820 ± 836</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.38 ± 0.516</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>16.8 ± 3.73</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>79.3 ± 22.5</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 34, 35]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Vandortuzumab vedotin</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1231</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3122 ± 53.0<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>3384</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>5.84</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>17.4</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>75.4</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[26, 28]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>DEDN6526A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1259</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2673<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>2897</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>4.62</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>22.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>60.1</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DMOT4039A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1010</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2308<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2006</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3.8</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>30.2</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>96.0</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DMUC5754A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1153</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1825<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>2618</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>5.12</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>25.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>85.3</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5]</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="100%" nowrap colspan=8 style='width:100.0%;border:none;padding:
  0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>DFRF4539A</span></b></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="10%" nowrap style='width:10.56%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:.1in;
  line-height:normal'><b><span style='font-size:10.0pt'>2.4</span></b></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>1233</span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3253<sup>a</sup></span></p>
  </td>
  <td width="13%" nowrap style='width:13.12%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>3774</span></p>
  </td>
  <td width="13%" style='width:13.12%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>4.88</span></p>
  </td>
  <td width="12%" nowrap style='width:12.44%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>16.6</span></p>
  </td>
  <td width="11%" nowrap style='width:11.36%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt;color:black'>77.4</span></p>
  </td>
  <td width="13%" style='width:13.14%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span
  style='font-size:10.0pt;color:black'>[5, 23]</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='text-indent:0in'><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=30 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image040.png"></span><span
style='font-size:10.0pt;line-height:150%'> </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=41 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image041.png"></span><span
style='font-size:10.0pt;line-height:150%'>, </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=37 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image042.png"></span><span
style='font-size:10.0pt;line-height:150%'> were converted to nanomolar
concentration units, CL and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:8.0pt'><img width=17 height=23
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image043.png"></span><span
style='font-size:10.0pt;line-height:150%'> were presented as per body weight
units, and in case the unit was not reported as per body weight units, the
reported values were divided by 70 kg</span></p>

<p class=MsoNormal style='text-indent:0in'><sup><span style='font-size:10.0pt;
line-height:150%'>a </span></sup><span style='font-size:10.0pt;line-height:
150%'>Values not available from the literature and were calculated based on
digitalized concentration-time profiles</span></p>

<p class=MsoNormal style='text-indent:0in'><sup><span style='font-size:10.0pt;
line-height:150%'>b </span></sup><span style='font-size:10.0pt;line-height:
150%'>Data are shown as mean ± standard deviation (SD) of reported values from
multiple references. When the value was reported in one literature, only the
mean value was provided</span></p>

</div>

<span style='font-size:10.0pt;line-height:150%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection9>

<h1 style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:
.5in;text-indent:.5in;line-height:115%'>Table 6. <span style='font-weight:normal'>Estimated
</span><span style='font-weight:normal'>parameter values for the generalized PK
model for MMAE-based ADCs.</span></h1>

<div align=center>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="53%"
 style='width:53.84%;border-collapse:collapse'>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;border:none;border-top:
  solid windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>PK
  parameter (unit)</span></b></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;border:none;border-top:
  solid windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>Estimate
  (%RSE)</span></b></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=36 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image051.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.0125 (6.39)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=45 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image052.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.0247 (7.98)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=37 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image053.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.0509 (2.57)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=37 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image054.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.0612 (8.47)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=26 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image055.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.861 (3.39)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=35 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image034.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>13.7 (2.51)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=27 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image032.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.430 (1.08)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=27 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image033.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>1.24 (10.0)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=24 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image056.png"></span><span
  style='font-size:10.0pt;color:black'> (1/day)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.104 (9.30)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=41 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image057.png"></span><span
  style='font-size:10.0pt;color:black'> (1/day)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>0.135 (5.33)</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=MsoNormal style='margin-left:.2in;line-height:normal'><span
  style='font-size:10.0pt;font-family:"Calibri",sans-serif;color:black'>&nbsp;</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='font-size:10.0pt;color:black'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='text-indent:0in;line-height:normal'><b><span
  style='font-size:10.0pt;color:black'>Random effect<sup>a</sup></span></b></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='text-indent:0in;line-height:normal'><b><span
  style='font-size:10.0pt;color:black'>CV% (%RSE)</span></b></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=36 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image051.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>60.2 (8.47)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=45 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image052.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>60.0 (12.4)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=37 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image053.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>24.8 (7.81)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=37 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image054.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>82.9 (10.0)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=26 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image055.png"></span><span
  style='font-size:10.0pt;color:black'> (L/day/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>27.4 (9.33)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=27 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image033.png"></span><span
  style='font-size:10.0pt;color:black'> (L/kg)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>82.2 (12.0)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=24 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image056.png"></span><span
  style='font-size:10.0pt;color:black'> (1/day)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>86.7 (9.15)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="53%" nowrap colspan=2 style='width:53.2%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
  position:relative;top:8.0pt'><img width=41 height=23
  src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image057.png"></span><span
  style='font-size:10.0pt;color:black'> (1/day)</span></p>
  </td>
  <td width="46%" nowrap colspan=3 style='width:46.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>34.3 (13.8)</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width="46%" nowrap style='width:46.44%;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=MsoNormal style='line-height:normal'><span style='font-size:10.0pt;
  color:black'>&nbsp;</span></p>
  </td>
  <td width="21%" nowrap colspan=2 style='width:21.86%;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='font-size:10.0pt'>&nbsp;</span></p>
  </td>
  <td width="31%" colspan=2 style='width:31.7%;padding:0in 5.4pt 0in 5.4pt;
  height:1.0pt'>
  <p class=MsoNormal align=center style='text-align:center;line-height:normal'><span
  style='font-size:10.0pt'>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:.2in'>
  <td width="46%" nowrap valign=top style='width:46.44%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=left style='text-align:left;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt;color:black'>Residual
  error<sup>b</sup></span></b></p>
  </td>
  <td width="26%" nowrap colspan=3 valign=top style='width:26.8%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Additive (nM)</span></b></p>
  </td>
  <td width="26%" valign=top style='width:26.78%;padding:0in 5.4pt 0in 5.4pt;
  height:.2in'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><b><span style='font-size:10.0pt'>Proportional (%)</span></b></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="46%" nowrap style='width:46.44%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>ADC</span></p>
  </td>
  <td width="26%" nowrap colspan=3 style='width:26.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.384 (19.8)</span></p>
  </td>
  <td width="26%" style='width:26.78%;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>14.0 (4.82)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="46%" nowrap style='width:46.44%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>Total antibody</span></p>
  </td>
  <td width="26%" nowrap colspan=3 style='width:26.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>1.34 (15.3)</span></p>
  </td>
  <td width="26%" style='width:26.78%;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>18.1 (5.95)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="46%" nowrap style='width:46.44%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>Unconjugated MMAE</span></p>
  </td>
  <td width="26%" nowrap colspan=3 style='width:26.8%;padding:0in 5.4pt 0in 5.4pt;
  height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.198 (12.4)</span></p>
  </td>
  <td width="26%" style='width:26.78%;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>21.4 (7.59)</span></p>
  </td>
 </tr>
 <tr style='height:15.85pt'>
  <td width="46%" nowrap style='width:46.44%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal style='margin-left:.2in;text-indent:0in;line-height:normal'><span
  style='font-size:10.0pt;color:black'>Conjugated MMAE</span></p>
  </td>
  <td width="26%" nowrap colspan=3 style='width:26.8%;border:none;border-bottom:
  solid windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>0.466 (26.4)</span></p>
  </td>
  <td width="26%" style='width:26.78%;border:none;border-bottom:solid windowtext 1.5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.85pt'>
  <p class=MsoNormal align=center style='text-align:center;text-indent:0in;
  line-height:normal'><span style='font-size:10.0pt'>11.7 (7.60)</span></p>
  </td>
 </tr>
 <tr height=0>
  <td width=192 style='border:none'></td>
  <td width=30 style='border:none'></td>
  <td width=67 style='border:none'></td>
  <td width=22 style='border:none'></td>
  <td width=110 style='border:none'></td>
 </tr>
</table>

</div>

<p class=MsoNoSpacing style='margin-left:1.0in'><span style='font-size:10.0pt;
font-family:"Times New Roman",serif'>%RSE relative standard error</span></p>

<p class=MsoNoSpacing style='margin-left:1.0in'><sup><span style='font-size:
10.0pt;font-family:"Times New Roman",serif'>a </span></sup><span
style='font-size:10.0pt;font-family:"Times New Roman",serif'>Random effect
expressed as %CV indicating variability among individual study groups with
different MMAE-based ADC and doses</span></p>

<p class=MsoNoSpacing style='margin-left:1.0in'><sup><span style='font-size:
10.0pt;font-family:"Times New Roman",serif'>b </span></sup><span
style='font-size:10.0pt;font-family:"Times New Roman",serif'>Combined
proportional and additive residual error models selected for all analytes in
the PK model</span></p>

<span style='font-size:10.0pt;line-height:107%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:8.0pt;text-align:left;
text-indent:0in;line-height:107%'><span style='font-size:10.0pt;line-height:
107%'>&nbsp;</span></p>

</div>

<b><span lang=EN-GB style='font-size:12.0pt;line-height:200%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span></b>

<div class=WordSection10>

<p class=MsoNormal style='text-indent:0in;line-height:200%'><b><span
lang=EN-GB style='font-size:12.0pt;line-height:200%'>Figure legends</span></b></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 1.</span></b><span lang=EN-GB> Structures of generalized PK
models for MMAE-based ADCs. The PK model describes conjugates (including
conjugated antibody and conjugated MMAE), unconjugated MMAE, and naked
antibody, where each analyte is captured using two-compartment models. The
degradation of conjugated MMAE is assumed to release all its conjugated
payloads equivalent to the average DAR value at the given time, as described
via </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=41 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image014.png"></span><span
lang=EN-GB>·DAR. The deconjugation of conjugated MMAE is assumed to release one
conjugated payload, denoted via </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=46 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image015.png"></span><span
style='color:black'>.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 2. </span></b><span lang=EN-GB>Clinical PK profiles of four ADC
analytes across various MMAE-based ADCs. The collected PK profiles of ADC
(conjugated antibody), total antibody, unconjugated MMAE, and conjugated MMAE
for various ADCs are dose-normalized to 2.4 mg/kg and plotted together. For
ADCs with multiple-dose PK data, only the PK profiles after the first dose are
shown.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 3. </span></b><span lang=EN-GB>Clinical PK profiles of
different ADC analytes for individual MMAE-based ADCs. The collected PK
profiles of ADC (conjugated antibody), total antibody, unconjugated MMAE, and
conjugated MMAE for individual ADCs are dose-normalized to 2.4 mg/kg and
plotted together.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 4. </span></b><span lang=EN-GB>Dose-exposure relationships for
ADC analytes using linear regression analysis based on literature-reported
values. The relationships between exposure matrices (</span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span> <span
lang=EN-GB>or AUC) and dose are shown for <b>(a)</b> conjugated MMAE, <b>(b)</b>
unconjugated MMAE, <b>(c)</b> ADC, and <b>(d)</b> total mAb. Correlation
coefficients (R) are provided for each relationship. Equations describing the
relationships between dose (mg/kg) and </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span><span
lang=EN-GB> or AUC for the four analytes are provided. Literature-reported </span><span
style='font-size:11.0pt;line-height:150%;font-family:"Times New Roman",serif;
position:relative;top:9.0pt'><img width=30 height=26
src="Generalized%20PK%20Model%20for%20MMAE%20ADCs_files/image001.png"></span><span
lang=EN-GB> or AUC values across the dose range are shown as dots, and the
shaded area indicates the 90% CI.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 5.</span></b><span lang=EN-GB> Model simulation of PK profiles
for four ADC analytes (ADC, total antibody, unconjugated MMAE, and conjugated
MMAE) in MMAE-based ADCs administered at 2.4 mg/kg every 3 weeks for 4 doses.
The simulated PK profiles are superimposed with observed data dose-normalized
to 2.4 mg/kg (red dots). The simulations account for the random effect of PK
parameters. The black line represents the median, and the shaded area
represents the 90% CI.</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 6.</span></b><span lang=EN-GB> Diagnostic plots for four ADC
analytes (ADC, total antibody, unconjugated MMAE, and conjugated MMAE) for
MMAE-based ADCs. The plots display population and individual predictions versus
observed concentrations, with the identity line (<i>solid line</i>) and 2-fold
boundary lines (<i>dashed lines</i>).</span></p>

<p class=MsoNormal style='margin-top:6.0pt;line-height:200%'><b><span
lang=EN-GB>Fig. 7.</span></b><span lang=EN-GB> Visual predictive check (VPC) for
four ADC analytes (ADC, total antibody, unconjugated MMAE, and conjugated MMAE)
in MMAE-based ADCs. The solid lines represent the 50<sup>th</sup> percentile of
the observed data, while the dashed lines depict the 5<sup>th</sup> and 95<sup>th</sup>
percentiles. The red shaded areas represent the 95% CI for the 50<sup>th</sup>
percentile, and the blue shaded areas represent the 95% CI for the 5<sup>th</sup>
and 95<sup>th</sup> percentiles, derived from 1000 stochastic profiles simulated
using the generalized PK model.</span></p>

<p class=MsoNoSpacing><span style='font-size:10.0pt;font-family:"Times New Roman",serif'>&nbsp;</span></p>

<p class=MsoNormal style='text-indent:0in'><span style='font-size:10.0pt;
line-height:150%'>&nbsp;</span></p>

</div>

</body>

</html>
